STOCK TITAN

Joshua B. Cohen plans to sell 57,529 AMLX shares (AMLX)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

AMLX lists insider resale activity by Joshua B. Cohen: a planned disposition of 57,529 common shares tied to vesting restricted stock units on 03/02/2026 and multiple sales in the prior three months. The excerpt shows sales of 7,715 (01/06/2026), 136,193 (01/15/2026), 1,974 (01/16/2026), and 15,500 (02/02/2026).

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does AMLX's Form 144 filing disclose about insider Joshua B. Cohen?

It discloses planned and recent sales of AMLX common shares by Joshua B. Cohen, including 57,529 tied to vesting RSUs. The filing lists prior open-market sales of 7,715; 136,193; 1,974; and 15,500 shares on specified January–February 2026 dates.

How many shares are listed as to be sold on the AMLX Form 144 dated 03/02/2026?

The filing lists 57,529 common shares to be sold on 03/02/2026 in connection with vesting restricted stock units. The entry is labeled as an issuer-related vesting disposition.

Which dates show prior AMLX insider sales by Joshua B. Cohen in the last three months?

The excerpt records prior sales on 01/06/2026, 01/15/2026, 01/16/2026, and 02/02/2026. Each row lists the number of common shares sold on those dates.

Are the past three months' sale quantities by Joshua B. Cohen provided in the AMLX excerpt?

Yes. The filing shows specific sale quantities: 7,715, 136,193, 1,974, and 15,500 shares tied to the dates in January–February 2026. No aggregate total is given in the excerpt.

Does the Form 144 excerpt indicate the method or recipient of the 57,529-share disposition?

The entry is described as linked to the vesting of restricted stock units, with the issuer listed; the filing does not specify sales methods or purchasers in the provided excerpt.
Amylyx Pharmaceuticals

NASDAQ:AMLX

AMLX Rankings

AMLX Latest News

AMLX Latest SEC Filings

AMLX Stock Data

1.68B
92.94M
Biotechnology
Pharmaceutical Preparations
Link
United States
CAMBRIDGE